• Something wrong with this record ?

Effect of O-methyl-β-cyclodextrin-modified magnetic nanoparticles on the uptake and extracellular level of l-glutamate in brain nerve terminals

D. Horák, M. Beneš, Z. Procházková, M. Trchová, A. Borysov, A. Pastukhov, K. Paliienko, T. Borisova,

. 2017 ; 149 (-) : 64-71. [pub] 20161004

Language English Country Netherlands

Document type Journal Article

Changes in cholesterol concentration in the plasma membrane of presynaptic nerve terminals nonspecifically modulate glutamate transport and homeostasis in the central nervous system. Reduction of the cholesterol content in isolated rat brain nerve terminals (synaptosomes) using cholesterol-depleting agents decreases the glutamate uptake and increases the extracellular level of glutamate in nerve terminals. Extraction of cholesterol from the plasma membrane and its further removal from the synaptosomes by external magnetic field can be achieved by means of magnetic nanoparticles with immobilized cholesterol-depleting agent such as O-methyl-β-cyclodextrin (MCD). A simple approach is developed for preparation of maghemite (γ-Fe2O3) nanoparticles containing chemically bonded MCD. The method is based on preparation of a silanization agent containing MCD. It is synthesized by the reaction of triethoxy(3-isocyanatopropyl)silane with MCD. Base-catalyzed silanization of superparamagnetic γ-Fe2O3 provides a relatively stable colloid product containing 48μmol of MCDg(-1). MCD-modified γ-Fe2O3 nanoparticles decrease the initial rate of the uptake and accumulation of l-[(14)C]glutamate and increase the extracellular l-[(14)C]glutamate level in the preparation of nerve terminals. The effect of MCD-immobilized nanoparticles is the same as that of MCD solution; moreover, magnetic manipulation of the nanoparticles enables removal of bonded cholesterol.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013489
003      
CZ-PrNML
005      
20170502100047.0
007      
ta
008      
170413s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.colsurfb.2016.10.007 $2 doi
035    __
$a (PubMed)27721167
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Horák, Daniel $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic. Electronic address: horak@imc.cas.cz.
245    10
$a Effect of O-methyl-β-cyclodextrin-modified magnetic nanoparticles on the uptake and extracellular level of l-glutamate in brain nerve terminals / $c D. Horák, M. Beneš, Z. Procházková, M. Trchová, A. Borysov, A. Pastukhov, K. Paliienko, T. Borisova,
520    9_
$a Changes in cholesterol concentration in the plasma membrane of presynaptic nerve terminals nonspecifically modulate glutamate transport and homeostasis in the central nervous system. Reduction of the cholesterol content in isolated rat brain nerve terminals (synaptosomes) using cholesterol-depleting agents decreases the glutamate uptake and increases the extracellular level of glutamate in nerve terminals. Extraction of cholesterol from the plasma membrane and its further removal from the synaptosomes by external magnetic field can be achieved by means of magnetic nanoparticles with immobilized cholesterol-depleting agent such as O-methyl-β-cyclodextrin (MCD). A simple approach is developed for preparation of maghemite (γ-Fe2O3) nanoparticles containing chemically bonded MCD. The method is based on preparation of a silanization agent containing MCD. It is synthesized by the reaction of triethoxy(3-isocyanatopropyl)silane with MCD. Base-catalyzed silanization of superparamagnetic γ-Fe2O3 provides a relatively stable colloid product containing 48μmol of MCDg(-1). MCD-modified γ-Fe2O3 nanoparticles decrease the initial rate of the uptake and accumulation of l-[(14)C]glutamate and increase the extracellular l-[(14)C]glutamate level in the preparation of nerve terminals. The effect of MCD-immobilized nanoparticles is the same as that of MCD solution; moreover, magnetic manipulation of the nanoparticles enables removal of bonded cholesterol.
650    _2
$a zvířata $7 D000818
650    _2
$a biologický transport $x účinky léků $7 D001692
650    _2
$a mozek $x účinky léků $x metabolismus $7 D001921
650    _2
$a radioizotopy uhlíku $7 D002250
650    _2
$a buněčná membrána $x účinky léků $x metabolismus $7 D002462
650    _2
$a cholesterol $x izolace a purifikace $x metabolismus $x farmakologie $7 D002784
650    _2
$a železité sloučeniny $x chemie $7 D005290
650    _2
$a kyselina glutamová $x metabolismus $7 D018698
650    _2
$a kinetika $7 D007700
650    _2
$a magnetické nanočástice $x chemie $7 D058185
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové potenciály $x účinky léků $7 D008564
650    _2
$a presynaptická zakončení $x účinky léků $x metabolismus $7 D017729
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a silany $x chemie $7 D012821
650    _2
$a synaptozomy $x účinky léků $x metabolismus $7 D013574
650    _2
$a beta-cyklodextriny $x chemie $x farmakologie $7 D047392
655    _2
$a časopisecké články $7 D016428
700    1_
$a Beneš, Milan $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
700    1_
$a Procházková, Zuzana $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
700    1_
$a Trchová, Miroslava $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
700    1_
$a Borysov, Arsenii $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
700    1_
$a Pastukhov, Artem $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
700    1_
$a Paliienko, Konstantin $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
700    1_
$a Borisova, Tatiana $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
773    0_
$w MED00180202 $t Colloids and surfaces. B, Biointerfaces $x 1873-4367 $g Roč. 149, č. - (2017), s. 64-71
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27721167 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170502100413 $b ABA008
999    __
$a ok $b bmc $g 1199954 $s 974267
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 149 $c - $d 64-71 $e 20161004 $i 1873-4367 $m Colloids and surfaces. B, Biointerfaces $n Colloids surf., B Biointerfaces $x MED00180202
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...